146 related articles for article (PubMed ID: 9199880)
1. Increased susceptibility of Alzheimer's disease temporal cortex to oxygen free radical-mediated processes.
McIntosh LJ; Trush MA; Troncoso JC
Free Radic Biol Med; 1997; 23(2):183-90. PubMed ID: 9199880
[TBL] [Abstract][Full Text] [Related]
2. Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease.
Marcus DL; Thomas C; Rodriguez C; Simberkoff K; Tsai JS; Strafaci JA; Freedman ML
Exp Neurol; 1998 Mar; 150(1):40-4. PubMed ID: 9514828
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein E allele-dependent antioxidant activity in brains with Alzheimer's disease.
Tamaoka A; Miyatake F; Matsuno S; Ishii K; Nagase S; Sahara N; Ono S; Mori H; Wakabayashi K; Tsuji S; Takahashi H; Shoji S
Neurology; 2000 Jun; 54(12):2319-21. PubMed ID: 10881261
[TBL] [Abstract][Full Text] [Related]
4. Enhanced inhibition of free radical-induced deoxyribose breakdown by Alzheimer brain homogenates.
Volicer L; Wells JM; McKee AC; Kowall NW
Neurosci Lett; 1999 Aug; 270(3):169-72. PubMed ID: 10462121
[TBL] [Abstract][Full Text] [Related]
5. Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease.
Lovell MA; Ehmann WD; Butler SM; Markesbery WR
Neurology; 1995 Aug; 45(8):1594-601. PubMed ID: 7644059
[TBL] [Abstract][Full Text] [Related]
6. Free radicals in the genesis of Alzheimer's disease.
Richardson JS
Ann N Y Acad Sci; 1993 Sep; 695():73-6. PubMed ID: 8239316
[TBL] [Abstract][Full Text] [Related]
7. Increased susceptibility to plasma lipid peroxidation in Alzheimer disease patients.
Galbusera C; Facheris M; Magni F; Galimberti G; Sala G; Tremolada L; Isella V; Guerini FR; Appollonio I; Galli-Kienle M; Ferrarese C
Curr Alzheimer Res; 2004 May; 1(2):103-9. PubMed ID: 15975074
[TBL] [Abstract][Full Text] [Related]
8. Catecholamines inhibit lipid peroxidation in young, aged, and Alzheimer's disease brain.
Andorn AC; Pappolla MA
Free Radic Biol Med; 2001 Aug; 31(3):315-20. PubMed ID: 11461768
[TBL] [Abstract][Full Text] [Related]
9. Protective role of vitamin E on the oxidative stress in Hansen's disease (Leprosy) patients.
Vijayaraghavan R; Suribabu CS; Sekar B; Oommen PK; Kavithalakshmi SN; Madhusudhanan N; Panneerselvam C
Eur J Clin Nutr; 2005 Oct; 59(10):1121-8. PubMed ID: 16015260
[TBL] [Abstract][Full Text] [Related]
10. Role of Vitamin E in the Treatment of Alzheimer's Disease: Evidence from Animal Models.
Gugliandolo A; Bramanti P; Mazzon E
Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29168797
[TBL] [Abstract][Full Text] [Related]
11. The redox chemistry of the Alzheimer's disease amyloid beta peptide.
Smith DG; Cappai R; Barnham KJ
Biochim Biophys Acta; 2007 Aug; 1768(8):1976-90. PubMed ID: 17433250
[TBL] [Abstract][Full Text] [Related]
12. Oxidative damage and protection by antioxidants in the frontal cortex of Alzheimer's disease is related to the apolipoprotein E genotype.
Ramassamy C; Averill D; Beffert U; Bastianetto S; Theroux L; Lussier-Cacan S; Cohn JS; Christen Y; Davignon J; Quirion R; Poirier J
Free Radic Biol Med; 1999 Sep; 27(5-6):544-53. PubMed ID: 10490274
[TBL] [Abstract][Full Text] [Related]
13. Melatonin inhibits iron-induced epileptic discharges in rats by suppressing peroxidation.
Kabuto H; Yokoi I; Ogawa N
Epilepsia; 1998 Mar; 39(3):237-43. PubMed ID: 9578039
[TBL] [Abstract][Full Text] [Related]
14. A Study of Aβ Oligomers in the Temporal Cortex and Cerebellum of Patients with Neuropathologically Confirmed Alzheimer's Disease Compared to Aged Controls.
Savioz A; Giannakopoulos P; Herrmann FR; Klein WL; Kövari E; Bouras C; Giacobini E
Neurodegener Dis; 2016; 16(5-6):398-406. PubMed ID: 27400224
[TBL] [Abstract][Full Text] [Related]
15. Autopsy samples of Alzheimer's cortex show increased peroxidation in vitro.
Subbarao KV; Richardson JS; Ang LC
J Neurochem; 1990 Jul; 55(1):342-5. PubMed ID: 2355227
[TBL] [Abstract][Full Text] [Related]
16. The cortical topography of temporal lobe hypometabolism in early Alzheimer's disease.
Jagust WJ; Eberling JL; Richardson BC; Reed BR; Baker MG; Nordahl TE; Budinger TF
Brain Res; 1993 Dec; 629(2):189-98. PubMed ID: 8111623
[TBL] [Abstract][Full Text] [Related]
17. Scavenger receptor class B type I expression and elemental analysis in cerebellum and parietal cortex regions of the Alzheimer's disease brain.
Srivastava RA; Jain JC
J Neurol Sci; 2002 Apr; 196(1-2):45-52. PubMed ID: 11959156
[TBL] [Abstract][Full Text] [Related]
18. Oxidative stress hypothesis in Alzheimer's disease.
Markesbery WR
Free Radic Biol Med; 1997; 23(1):134-47. PubMed ID: 9165306
[TBL] [Abstract][Full Text] [Related]
19. Strategy to reduce free radical species in Alzheimer's disease: an update of selected antioxidants.
Di Domenico F; Barone E; Perluigi M; Butterfield DA
Expert Rev Neurother; 2015 Jan; 15(1):19-40. PubMed ID: 25243342
[TBL] [Abstract][Full Text] [Related]
20. Antioxidant pathways in Alzheimer's disease: possibilities of intervention.
Viña J; Lloret A; Giraldo E; Badia MC; Alonso MD
Curr Pharm Des; 2011 Dec; 17(35):3861-4. PubMed ID: 21933145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
